Mankind Pharma
₹2,535
- Market Cap
- ₹93,730Cr.
- P/E Ratio
- 44.0
- P/B Ratio
- 6.42
- EPS (TTM)
- ₹57.61
- Div Yield
- 0.04%
- ROCE
- 13.5%
- ROE
- 13.1%
52W Low: ₹1,91052W High: ₹2,642
Themes:💊 Pharma & CDMO
Descriptive screens built from published data — not investment advice.
At a glance
- Sales have grown 18.0% a year over three years.
- Debt is 0.39× its shareholders’ equity.
From reported financials and exchange prices. Descriptive only, not advice.
Mankind_Pharma — Price
Interval
Style
Failed: 503
Evenstocks Score
Middle third
Overall
Valuation
Quality
Fundamental
Growth
Investment Checklist
Quick assessment based on key parametersPerformance
N/ATrailing return unavailableValuation
P/E 44.0P/E: 44.0 | P/B: 6.42Growth
GrowingSales CAGR — 3Y: 18% · 1Y: 14%Profitability
ModerateROCE: 13.5% | ROE: 13.1%Key Metrics
Valuation
PEG Ratio 2.59
Price / Sales 6.36x
Price / FCF 39.3x
Book Value ₹395
Margins & returns
Operating Margin 26%
Net Margin 14.0%
Return on Assets 7.5%